|Probiotics show potential against common cold: Study|
|Tuesday, 21 September 2010 00:00|
Daily supplements with probiotic Lactobacillus strains may reduce the incidence of acquiring the common cold by 12 percent, according to new research from probiotic player Probi.
Results of a randomised, parallel, double-blind placebo-controlled study with 272 subjects showed that daily consumption of Lactobacillus plantarum HEAL 9 (DSM 15312) and Lactobacillus paracasei 8700:2 (DSM 13434) reduced the incidence of one or more episodes of the common cold from 67 percent in the placebo group to 55 percent, according to findings published in the European Journal of Nutrition.
Furthermore, the number of days of symptoms for the cold was significantly reduced in people taking the probiotic supplements, from an average of 8.6 to 6.2, compared with placebo.
"Intake of the probiotic strains Lactobacillus plantarum HEAL 9 (DSM 15312) and Lactobacillus paracasei 8700:2 (DSM 13434) reduces the risk of acquiring common cold infections," state the researchers, led by Anna Berggren from Sweden's Probi AB.